K562-Derived Whole-Cell Vaccine Enhances Antitumor Responses of CAR-Redirected Virus-Specific Cytotoxic T Lymphocytes in Vivo
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-2998
Full Text
Open PDFAbstract
Available in full text
Date
February 17, 2015
Authors
Publisher
American Association for Cancer Research (AACR)